Novavax
NVAX
167 hedge funds and large institutions have $1.46B invested in Novavax in 2015 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 25 closing their positions.
64% more capital invested
Capital invested by funds: $889M → $1.46B (+$567M)
60% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 25
10% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 50
9% more funds holding
Funds holding: 153 → 167 (+14)
47% less call options, than puts
Call options by funds: $10M | Put options by funds: $19M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$115M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$60.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$16.4M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$14.7M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
-$14.1M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$11.9M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$9.27M |
NVAX Hedge Fund Activity: Q1 2015 in Review
167 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2015, worth a combined $1.46B — up 64% from $889M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new NVAX positions and 25 closed out — a net gain of 15 holders — while 55 added to existing stakes and 50 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $115M. The largest seller was Invesco, cutting an estimated $16.4M.
- 167 institutional investors held Novavax (NVAX) as of Q1 2015, up from 153 in Q4 2014.
- Funds reported $1.46B of Novavax stock for Q1 2015, up 64% quarter-over-quarter.
- 40 funds opened new Novavax positions in Q1 2015 and 25 closed out, a net change of +15 holders.
- The largest Novavax buyer in Q1 2015 was First Trust Advisors, an estimated $115M added.
- The largest Novavax seller in Q1 2015 was Invesco, an estimated $16.4M sold.
Based on aggregated 13F filings for Q1 2015.